Single-Port Robotic System Feasible for Nipple-Sparing Mastectomy
By Lori Solomon HealthDay Reporter
THURSDAY, Feb. 1, 2024 -- The da Vinci single-port (SP) robotic system is feasible for performing nipple-sparing mastectomies, according to a study published online Jan. 17 in JAMA Surgery.
Deborah E. Farr, M.D., from the University of Texas Southwestern Medical Center in Dallas, and colleagues evaluated the feasibility of using the da Vinci SP (Intuitive Surgical) robotic system for nipple-sparing mastectomies. The analysis included 20 patients (40 breasts) undergoing bilateral single-port robotic nipple-sparing mastectomies (SPrNSM).
The researchers reported that the total duration of the procedure from incision to skin closure for both sides ranged from 205 to 351 minutes (median, 277 minutes). The median robotic time varied by cup size (A cup, 95 minutes; B cup, 140 minutes; C cup, 118 minutes; D cup, 114 minutes), with no inflection point in the learning curve. No cases were converted to open, and there were no immediate complications (e.g., hematoma, positive margins, or recurrence). Among the first 10 patients, 20 resected breasts had measurable nipple areolar complex (NAC) sensation at a range from four to 36 months after the index resection (65 percent), while among the second 10 patients, measurable NAC was preserved in 13 of 20 resected breasts two weeks following the index operation (65 percent).
"SPrNSM with immediate reconstruction was feasible and performed safely by an experienced breast surgeon with limited previous robotic training," the authors write.
One author reported being a member of the Surgical Safety Technologies Scientific Advisory Board.
Abstract/Full Text (subscription or payment may be required)
Editorial (subscription or payment may be required)
Disclaimer: Statistical data in medical articles provide general trends and do not pertain to individuals. Individual factors can vary greatly. Always seek personalized medical advice for individual healthcare decisions.
Source: HealthDay
Posted : 2024-02-02 02:15
Read more
- Leads Biolabs Receives Orphan Drug Designation from the US FDA for LBL-034, a Uniquely Designed, Highly Differentiated Anti-GPRC5D/CD3 Bispecific Antibody, for the Treatment of Multiple Myeloma
- Prenatal Cannabis Exposure May Impact Executive Function, Behavior at Age 5 Years
- Too Much Sitting Harms the Heart, Even in Folks Who Exercise
- Have an Implanted Defibrillator? Triple-Digit Heatwaves Could Pose Danger
- Duodenal ReCET Plus Semaglutide Can Prevent Need for Insulin in T2DM
- Most Patients Can Keep Using GLP-1 Weight Loss Meds Before Surgeries
Disclaimer
Every effort has been made to ensure that the information provided by Drugslib.com is accurate, up-to-date, and complete, but no guarantee is made to that effect. Drug information contained herein may be time sensitive. Drugslib.com information has been compiled for use by healthcare practitioners and consumers in the United States and therefore Drugslib.com does not warrant that uses outside of the United States are appropriate, unless specifically indicated otherwise. Drugslib.com's drug information does not endorse drugs, diagnose patients or recommend therapy. Drugslib.com's drug information is an informational resource designed to assist licensed healthcare practitioners in caring for their patients and/or to serve consumers viewing this service as a supplement to, and not a substitute for, the expertise, skill, knowledge and judgment of healthcare practitioners.
The absence of a warning for a given drug or drug combination in no way should be construed to indicate that the drug or drug combination is safe, effective or appropriate for any given patient. Drugslib.com does not assume any responsibility for any aspect of healthcare administered with the aid of information Drugslib.com provides. The information contained herein is not intended to cover all possible uses, directions, precautions, warnings, drug interactions, allergic reactions, or adverse effects. If you have questions about the drugs you are taking, check with your doctor, nurse or pharmacist.
Popular Keywords
- metformin obat apa
- alahan panjang
- glimepiride obat apa
- takikardia adalah
- erau ernie
- pradiabetes
- besar88
- atrofi adalah
- kutu anjing
- trakeostomi
- mayzent pi
- enbrel auto injector not working
- enbrel interactions
- lenvima life expectancy
- leqvio pi
- what is lenvima
- lenvima pi
- empagliflozin-linagliptin
- encourage foundation for enbrel
- qulipta drug interactions